04:57 PM EST, 02/18/2025 (MT Newswires) -- Pushkal Garg, Chief Medical Officer & Executive Vice President, Development & Medical Affairs, on February 13, 2025, sold 3,109 shares in Alnylam Pharmaceuticals ( ALNY ) for $787,904. Following the Form 4 filing with the SEC, Garg has control over a total of 12,670 common shares of the company, with 11,989 shares held directly and 681 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527625000009/xslF345X05/edgardoc.xml